Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 358861 - 358880 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (C03DA01) spironolactone (adm: O) | Spironolactone Medreg, tabl. powl., 25 mg | 100 szt., 25 mg , 100 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medregs.r.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Spironolactone Medreg, tabl. powl., 25 mg | 20 szt., 25 mg , 20 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medregs.r.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Verospiron, kaps. twarde, 100 mg | 30 szt., 100 mg , 30 kaps. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPlc. |
| Poland | (C03DA01) spironolactone (adm: O) | Verospiron, kaps. twarde, 50 mg | 30 szt., 50 mg , 30 kaps. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPlc. |
| Poland | (C03DA01) spironolactone (adm: O) | Spironol 100, tabl. powl., 100 mg | 20 szt., 100 mg , 20 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPolskaSp.zo.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Finospir, tabl., 25 mg | 30 szt., 25 mg , 30 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrionCorporation |
| Poland | (C03DA01) spironolactone (adm: O) | Finospir, tabl., 25 mg | 100 szt., 25 mg , 100 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrionCorporation |
| Poland | (C03DA01) spironolactone (adm: O) | Spironol, tabl., 25 mg | 20 szt., 25 mg , 20 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPolskaSp.zo.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Spironol, tabl., 25 mg | 100 szt., 25 mg , 100 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPolskaSp.zo.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Verospiron, tabl., 25 mg | 20 szt., 25 mg , 20 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPlc. |
| Poland | (C03DA01) spironolactone (adm: O) | Finospir, tabl., 50 mg | 30 szt., 50 mg , 30 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrionCorporation |
| Poland | (C03DA01) spironolactone (adm: O) | Finospir, tabl., 50 mg | 100 szt., 50 mg , 100 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrionCorporation |
| Poland | (C03DA01) spironolactone (adm: O) | Spironol, tabl. powl., 50 mg | 30 szt., 50 mg , 30 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPolskaSp.zo.o. |
| Poland | (C03DA01) spironolactone (adm: O) | Spironol, tabl. powl., 50 mg | 60 szt., 50 mg , 60 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | GedeonRichterPolskaSp.zo.o. |
| Poland | (C03DA05) finerenone (adm: O) | Kerendia, tabl. powl., 10 mg | 14 szt., 10 mg , 14 tabl. | Retail price with vat |
$0-0 |
$0-0 |
Renal Insufficiency, Chronic;Diabetes Mellitus, Type 2 | BayerAG |
| Poland | (C03DA05) finerenone (adm: O) | Kerendia, tabl. powl., 20 mg | 14 szt., 20 mg , 14 tabl. | Retail price with vat |
$0-0 |
$0-0 |
Renal Insufficiency, Chronic;Diabetes Mellitus, Type 2 | BayerAG |
| Poland | (C03EA01) hydrochlorothiazide and potassium-sparing agents | Tialorid mite, tabl., 2,5+25 mg | 50 tabl., 2,5 mg + 25 mg , 50 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (C03EA01) hydrochlorothiazide and potassium-sparing agents | Tialorid, tabl., 5+50 mg | 50 tabl., 5 mg + 50 mg , 50 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (C03XA01) tolvaptan (adm: O) | Jinarc, tabl., 15 ; 45 mg | 28+28 szt., 15 mg; 45 mg , 56 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Polycystic Kidney, Autosomal Dominant | OtsukaPharmaceuticalNetherlandsB.V. |
| Poland | (C03XA01) tolvaptan (adm: O) | Jinarc, tabl., 30 ; 60 mg | 28+28 szt., 30 mg; 60 mg , 56 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Polycystic Kidney, Autosomal Dominant | OtsukaPharmaceuticalNetherlandsB.V. |
Pages
